Michel Meignan - Concepedia

Author

Michel Meignan

Also Known As

A Buiuc, M Meignan, M. MEIGNAN, M. Meignan, MICHEL MEIGNAN, Meignan, M, Meignan, M., Meignan, Michel, Michel A Meignan, Michel A. Meignan

352

Publications

18K

Citations

H-Index

152

Concepts

All Affiliations

Université Paris-Est Créteil Assistance Publique – Hôpitaux de Paris Hôpitaux Universitaires Henri-Mondor Inserm Centre Hospitalier Universitaire Henri-Mondor

About

Michel Meignan is an author at Université Paris-Est Créteil specializing in medicine, radiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	53	4.8K
2	Health Sciences	25	33	3.9K
3	Engineering	9	9	740
4	Public Health	3	3	59
5	Natural Sciences	1	1	18

Michel Meignan

135

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group Sally F. Barrington, N. George Mikhaeel, Lale Kostakoğlu, Journal of Clinical Oncology	2014	1.6K
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hervé Tilly, María Gomes da Silva, Umberto Vitolo, Annals of Oncology Hematological MalignancyLymphoid NeoplasiaMedicineSurgical PathologyHematology	2015	900
Report on the First International Workshop on interim-PET scan in lymphoma Michel Meignan, Andrea Gallamini, Michel Meignan, Leukemia & lymphoma/Leukemia and lymphoma	2009	731
Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial Marc André, T. Girinsky, Massimo Federico, Journal of Clinical Oncology	2017	515
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome Corinne Haïoun, Emmanuel Itti, Alain Rahmouni, Blood	2005	496
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma David M. Kurtz, Florian Scherer, Michael C. Jin, Journal of Clinical Oncology	2018	472
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun, Blood Advances	2020	387
Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial John Raemaekers, Marc André, Massimo Federico, Journal of Clinical Oncology	2014	381
EANM guidelines for ventilation/perfusion scintigraphy Marika Bajc, J. B. Neilly, Massimo Miniati, European Journal of Nuclear Medicine and Molecular Imaging Medical ImagingVentilationEanm GuidelinesPatient SafetyPerioperative Monitoring	2009	344
Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies Michel Meignan, Anne‐Ségolène Cottereau, Annibale Versari, Journal of Clinical Oncology	2016	325

Page 1